Does low income effects 5-year mortality of hepatocellular carcinoma patients? by 박은철 & 박은철
RESEARCH Open Access
Does low income effects 5-year mortality of
hepatocellular carcinoma patients?
Dong Jun Kim1,2†, Ji Won Yoo3†, Jong Wha Chang4, Takashi Yamashita5, Eun-Cheol Park6,7, Kyu-Tae Han8,
Seung Ju Kim9 and Sun Jung Kim2,10,11*
Abstract
Background: In Korea, the universal health system offers coverage to all members of society. Despite this, it is
unclear whether risk of death from hepatocellular carcinoma (HCC) varies depending on income. We evaluated the
impact of low income on HCC mortality.
Methods: The Korean National Health Insurance sampling cohort was used to identify new HCC cases (n = 7325)
diagnosed between 2004 and 2008, and the Korean Community Health Survey data were used to investigate
community-level effects. The main outcome was 5-year all-cause mortality risk, and Cox proportional hazard models
were applied to investigate the individual- and community-level factors associated with the survival probability of
HCC patients.
Results: From 2004 to 2008, there were 4658 new HCC cases among males and 2667 new cases among females.
The 5-year survival proportion of males was 68%, and the incidence per person-year was 0.768; the female survival
proportion was 78%, and the incidence per person-year was 0.819. Lower income was associated with higher
hazard ratio (HR), and HCC patients with hepatitis B (HBV), alcoholic liver cirrhosis, and other types of liver cirrhosis
had higher HRs than those without these conditions. Subgroup analyses showed that middle-aged men were most
vulnerable to the effects of low income on 5-year mortality, and community-level characteristics were associated
with survival of HCC patients.
Conclusion: Having a low income significantly affected the overall 5-year mortality of Korean adults who were
newly diagnosed with HCC from 2004 to 2008. Middle-aged men were the most vulnerable. We believe our
findings will be useful to healthcare policymakers in Korea as well as to healthcare leaders in countries with NHI
programs who need to make important decisions about allocation of limited healthcare resources according to a
consensually accepted and rational framework.
Keywords: Hepatocellular carcinoma, Liver Cancer, Low income, Mortality, Multi-level analysis, Cox proportional
hazard model
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Background
Mortality rates due to hepatocellular carcinoma (HCC)
have tended to increase in many countries in recent de-
cades [1]. In 2018, HCC was the second most common
cause of cancer-related mortality in Korea, with a rate of
20.7 per 100,000 [2], which is two- to five-fold higher
than in most European countries and the United States
[1]. The Korean government has implemented many
cancer management policies to identify and resolve these
HCC problems [3]. However, the results of the policy
were not equal among all HCC patients in Korea [4].
In Korea, HCC is the most common cause of cancer
mortality in men aged 40–59 [3]. The consequent eco-
nomic loss in this age group was estimated to be US$2.8
billion in 2014, which is the largest economic deficit as-
sociated with any type of cancer in Korea [3]. Individual-
level biological and contextual factors, such as economic
conditions, can affect HCC mortality rates [5, 6]. Low in-
come, which is usually defined as the bottom 20% of the
income distribution in a country [7], can increase the
risk for mortality in HCC patients [5, 6]. Low income is
linked to barriers to both formal and informal access to
overall healthcare and, in turn, to HCC treatment [8].
Although there have been no nationwide studies on the
effects of income on HCC mortality under the universal
health system, a study of Ontario [9] residents showed
that HCC patients in the lowest income quintile had a
10% higher HCC-related mortality rate than other
groups [9].
In terms of socioeconomic factors, access to health in-
surance is a key factor that enables patients to benefit
from the most current treatments [10]. In Korea, under
the universal health system, health insurance coverage
applies to all members of society. However, individual
income is another factor that enables access to health
care because, in 2015, the mandatory public health in-
surance covered only 64% of all healthcare expenditures,
leaving 36% of these expenditures to be paid by private
supplementary insurance or individuals [7]. Uncovered
services included surcharges for specialists at general
hospitals, new and high-cost diagnostic or therapeutic
services, and private wards [11]. Standard coverage by
the National Health Insurance (NHI) can be insufficient
for Korean households in general and low-income adults
in particular [12]. To increase the financial protection
available in the event of catastrophic illness, the Korean
government expanded the NHI coverage for cancer pa-
tients in 2005; however, the gap between the benefits
available to low- and high-income cancer patients re-
mains unchanged [11, 12].
Furthermore, although a few studies have examined
the occurrence of and survival following diagnoses of
breast, prostate, and colorectal cancer as a function of
regional socioeconomic status (SES) [13–16], there has
been no comparable HCC-related research. This study
investigated the association between low income and
HCC mortality at the national level in Korea in the con-
text of community characteristics. We also evaluated
whether this association differed by age and sex and esti-




We used data from the Korean National Health Insur-
ance Service-National Sampling Cohort (NHIS-NSC),
which was collected based on a systematic sampling de-
sign in 2002–2013, to produce a nationally representa-
tive random sample of 1,025,340 individuals, as well as
the 2008 Korea Community Health Survey (KCHS) in-
volving data on 200,000 individuals obtained from 253
community health centers [17, 18]. To investigate the as-
sociations between individual- and community-level
characteristics and survival of HCC patients, we first
identified individuals diagnosed with HCC between 2002
and 2013 according to the International Classification of
Diseases, version 10 (ICD-10): C22. Then we excluded
patients diagnosed during 2002–2003 to ensure that our
sample was restricted to newly diagnosed HCC cases
under the assumption that, if an individual had no HCC
diagnosis in the entire two-year period, then the first
diagnosis of HCC from 2004 onward was new. This is
because the first diagnosis should be distinguished, tak-
ing into account the long disease cycle of cancer. We
also excluded patients diagnosed with HCC during
2009–2013 to further restrict the sample to only patients
who were followed for 60 months because it is impos-
sible to track the censoring that occurs during this
period; this criterion covered patients who were diag-
nosed during 2004–2008. Then we transposed the data-
set into a retrospective cohort design in which the unit
of analysis was information from each HCC patient.
These claims data consist of a single case of patient
medical use. We summarized each case into one patient
episode. After that, survival time was measured from the
first diagnosis to the time of death, and patients who did
not die were defined as survival. To evaluate each HCC
patient’s community-level characteristics, we summa-
rized each municipality’s characteristics from individuals
of the KCHS, conducted by the Korean Center for Dis-
ease Control and Prevention [17, 18]. Furthermore, we
matched individual- and community-level data and ob-
tained data on the characteristics of 7325 new HCC pa-
tients and their respective 238 municipalities (Fig. 1).
This study was reviewed and approved by the Institu-
tional Review Board of Soonchunhyang University
(2017–05-BM-014).
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Variables
The main outcomes were number of deaths and survival
time from HCC over the course of a 5-year follow-up
period. The index date was defined as the date of diag-
nosis. All-cause death data were included in the dataset;
however, cause of death could not be identified.
Individual-level variables were sex, year of HCC diagno-
sis, HCC etiology, patient age, income, and disability at
diagnosis of HCC. Patient ages were categorized into the
following groups (in years): 49 or younger, 50–59, 60–
69, and 70 or older. We categorized income into NHI
contribution quintiles: 1st quintile (20th or lower per-
centiles), 2nd quintile (21st–40th percentiles), 3rd quin-
tile (41st–60th percentiles), 4th quintile (61st–80th
percentiles), and 5th quintile (80th or higher percentiles)
[17, 19]. Data on the status (physical disability or all-
cause disability) and severity (grade 1 or 2, severe; grade
3–6, mild) of the disability were provided by the NHIS-
NSC based on evaluations performed by the treating
physician according to the specific guidelines established
by the Korean government [17, 18]. The etiologies of
HCC were defined as follows based on ICD-10 coding:
HBV, hepatitis c (HCV), alcoholic liver cirrhosis, and
other (non-viral non-alcoholic) liver cirrhosis. The
KCHS analyzed the following community-level variables
in 2008: current smoking rate, high-risk drinking rate,
percentage of residents who walk for exercise, obesity
rate, and percentage of college graduates. The current
smoking rate was defined as the percentage of people
who had smoked more than five packs (100 cigarettes)
in their lifetime and who were currently smoking
(smoked “daily” or “sometimes”). High-risk drinking was
defined as consuming seven or more (men) or five or
more (women) alcoholic drinks on the same occasion on
at least 2 days within the past 7 days. The percentage of
residents who walked for exercise was the percentage of
people who had walked more than 30min per day dur-
ing the last week (7 days). The obesity rate was defined
as percentage of people with a body mass index (BMI;
kg/m2) greater than 25.
Statistical analyses
We first examined the number and characteristics of in-
dividuals newly diagnosed with HCC during the 5-year
study period. The frequencies and relative percentages
were calculated for categorical variables, and χ2 tests
were performed to examine differences in each variable
by survival. The incidence per person-years and follow-
up period were examined as a function of patient char-
acteristics. Also, according to income level, the distribu-
tion of deaths and the person-years at deaths were
calculated for each variable, and a χ2 test was conducted
on the distribution. To investigate associations between
patient characteristics and death from HCC, after testing
Fig. 1 Flowchart of sample selection process
Kim et al. International Journal for Equity in Health          (2021) 20:151 Page 3 of 11
the proportionality assumptions by the Grambsch and
Therneau non-proportionality test and log (− log {S (t)})
plot, we used Cox proportional hazard models to esti-
mate hazard ratios (HRs) and corresponding 95% confi-
dence intervals (CIs). To identify the individual and
community factors associated with the survival probabil-
ity of HCC patients, we employed a multi-level survival
model to include regional-level random effects in an in-
dividual model. In addition, subgroup analyses were per-
formed by sex and age groups, trend analysis was
performed according to decrease in income level by
model, and the threshold for statistical significance was
set at p < 0.05 (two-tailed) for all analyses. All statistical
analyses were performed using SAS statistical software,
version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Patients and characteristics
Table 1 presents patient characteristics, number of
deaths, and mean survival times. The number of new
HCC cases from 2004 to 2008 was stable, with 4658
cases among males and 2667 cases among females. The
5-year survival proportion of males was 68%, and the in-
cidence per person-year was 0.768; the female survival
proportion was 78%, and the incidence per person-year
was 0.819. The mortality proportion of the highest in-
come group was 25%, while those of the 4th, 3rd, 2nd,
and 1st quintiles were 26, 28, 31, and 35%, respectively
(p < 0.001). Patients with liver cirrhosis had higher mor-
tality rates and shorter survival times than patients with-
out cirrhosis, but an inverse association was found for
patients with HBV or HCV. Table 2 shows death infor-
mation by income level. Table 2 presents, according to
income level, the distribution of deaths and the person-
years (PY) at deaths. There was a difference in the pro-
portion of deaths and the person-years according to in-
come group (1st quintile: the proportion = 67.2%, PY =
0.670; 2nd quintile: the proportion = 62.2%, PY = 0.669;
3rd quintile: the proportion = 66.9%, PY = 0.852; 4th
quintile: the proportion = 62.8%, PY = 0.725; 5th quintile:
the proportion = 60.9%, PY = 0.727).
Risk factors associated with mortality in HCC
Table 3 shows the hazard ratios of patients with HCC
according to both Cox proportional hazard models after
adjusting for all other covariates. The HRs of HCC pa-
tients increased with age and lower income (p < 0.001).
However, there were no significant differences between
those in the 4th and 5th quintiles of income (p = 0.161).
Furthermore, HCC patients with HBV, alcoholic liver
cirrhosis, and other types of liver cirrhosis had higher
HRs than those without these conditions (HBV: HRs =
1.172, p = 0.001; alcoholic liver cirrhosis: HRs = 2.187,
p < 0.001; other liver cirrhosis: HRs = 1.214 p = 0.023),
but the opposite pattern was found with regard to HCV
(HRs = 0.812, p < 0.001). The consequences of commu-
nity factors indicated that higher current smoking rates
and a greater percentage of college graduates in the
community were associated with higher HRs, and that
walking for exercise was associated with lower HRs
among HCC patients.
Subgroup analyses: HCC mortality by sex and age
Table 4 presents the results of multilevel multivariate
analyses of HCC mortality by sex and age. Among male
HCC patients, there was a difference in hazard ratio ac-
cording to income group (1st quintile: HR =1.422, p <
0.001; 2nd quintile: HR =1.560, p < 0.001; 3rd quintile:
HR =1.422, p < 0.001; reference group, 5th quintile).
Among HCC patients aged 50–59, there was a difference
in hazard ratio according to income group (4th quintile:
HR =1.509, p = 0.010; 3rd quintile: HR =1.593, p = 0.005;
2nd quintile: HR =2.089, p < 0.001; 1st quintile: HR =
2.197, p < 0.001; reference group, 5th quintile), and a sig-
nificant association also was found in those aged 49
years or younger and 60–69. However, there was no
such association among women or those aged 70 years
or older who had been diagnosed with HCC.
Table 5 presents the adjusted HRs of HCC mortality
for the lowest (1st quintile) and highest (5th quintile,
reference) income groups by sex and age considering
group interactions. Among male patients, the lowest in-
come group was associated with an increased risk for
HCC mortality compared to the highest income group
among patients 50–59 years and 49 years or younger
(HR = 1.956, p < .001 for 49 or younger; HR = 2.678,
p < .001 50–59 years). No such association was observed
among middle aged female patients (p = 0.151 for 49 or
younger; p = 0.734 50–59 years).
Discussion
Having a low income significantly affected the overall 5-
year mortality of Korean adults newly diagnosed with
HCC from 2004 to 2008. Middle-aged men with HCC
were more vulnerable to the effects of low income on 5-
year mortality than were younger and older men and
compared to women of all ages.
Our results are similar to those of previous research
on the association between health outcomes and SES
among HCC patients [20–22]. Although it is difficult to
compare health outcomes across health systems, HCC
patients living in economically deprived areas in the U.S.
are more likely to be diagnosed at an earlier age [20],
and those living in the U.K. have a shorter life expect-
ancy [21]. According to nationally representative U.S.
cancer registry data, health insurance type (uninsured
and Medicaid) and living in low-income communities
are associated with worse health outcomes in HCC
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Table 1 Patient characteristics, number of deaths, and mean survival periods
Variables N/Mean %/SD Number of deaths % p* Incidence
per person-years
Sex
Male 4658 63.6 1491 32% <.001 0.768
Female 2667 36.4 576 22% 0.819
Age group
49 or younger 2903 39.6 391 13% <.001 0.726
50–59 1772 24.2 395 22% 0.704
60–69 1574 21.5 600 38% 0.769
70 or older 1076 14.7 681 63% 0.888
Income (quintiles)
The 5th (highest) 2197 30.0 549 25% <.001 0.810
The 4th 1649 22.5 429 26% 0.720
The 3rd 1310 17.9 371 28% 0.774
The 2nd 1083 14.8 339 31% 0.821
The 1st (lowest) 1086 14.8 379 35% 0.789
Disability
None 6751 92.2 1824 27% <.001 0.791
Mild 459 6.3 189 41% 0.725
Severe 115 1.6 54 47% 0.673
New cases by year
2004 1478 20.2 450 30% 0.033 0.822
2005 1493 20.4 433 29% 0.776
2006 1324 18.1 387 29% 0.773
2007 1352 18.5 362 27% 0.819
2008 1678 22.9 435 26% 0.727
Hepatitis B
No 4749 64.8 1397 29% 0.002 0.822
Yes 2576 35.2 670 26% 0.708
Hepatitis C
No 5897 82.2 1730 29% 0.036 0.815
Yes 1304 17.8 337 26% 0.643
Alcoholic liver cirrhosis
No 6820 93.1 1786 26% <.001 0.810
Yes 505 6.9 281 56% 0.637
Other (non-viral, non-alcoholic) liver cirrhosis
No 6895 94.1 1901 28% <.001 0.801
Yes 430 5.9 166 39% 0.610
Regional Level
Current smoking rate† 23.6 3.0
High-risk drinking rate† 16.4 3.7
Walking exercise practice rate † 51.8 12.2
Obesity rate † 21.5 2.9
Percentage of college graduates † 34.2 12.6
*Chisq-test †Mean/SD
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patients [23]. The importance of monitoring and screen-
ing populations at risk for HCC, particularly young
adults with HBV and/or intravenous drug users, cannot
be stressed enough. Economic deprivation and poor ac-
cess to healthcare likely result in a greater risk for HCC
and a shorter survival time. Moreover, among U.S.
adults with chronic liver disease (CLD), low income con-
tributed to an increased risk for liver-related mortality
[24].
Sudden loss of wealth or a home has been shown to
constitute major psychological stressors among U.S.
adults [25–27]. Low-income adults with HCC might not
be able to afford surcharged services, such as specialty
doctors at general hospitals and new and high-cost tech-
nology; they also might show lower adherence to pre-
scribed medication regimens and delay needed medical
care during the early stages of HCC beyond the NHI
coverage deadline [8, 27]. In other words, due to the
possible burden of high out-of-pocket expenses, low-
income HCC patients might not be able to benefit from
new and high-cost diagnostic and therapeutic technology
that is not covered by the NHI [11, 12]. The effects of
low income on HCC mortality can extend to non-
medical domains, particularly among middle-aged
adults. Indeed, during the Great Recession of the late
2000s in the U.S., non-medical social welfare spending
Table 2 The proportion and survival time according to income of the death
Variables Income (quintiles)
The 1st (lowest) The 2nd The 3rd The 4th The 5th (highest) p*
% PY † % PY † % PY † % PY † % PY †
Sex
Male 39.4 0.763 37.0 0.853 33.4 0.776 29.8 0.703 26.8 0.772 0.094
Female 27.8 0.854 20.8 0.729 19.4 0.769 18.8 0.779 22.0 0.898
Age group
49 or younger 18.2 0.963 17.6 0.975 14.6 0.851 12.0 0.731 9.6 0.935 <.001
9 29.1 0.781 28.3 0.908 22.4 0.674 22.7 0.770 15.5 0.774
60–69 41.8 0.701 41.1 0.760 45.2 0.801 36.1 0.639 31.6 0.662
70 or older 67.2 0.670 62.2 0.669 66.9 0.852 62.8 0.725 60.9 0.727
Disability
None 33.6 0.820 30.2 0.823 27.0 0.767 25.0 0.736 23.9 0.819 <.001
Mild 44.8 0.747 40.8 0.742 41.4 0.761 38.1 0.611 41.0 0.792
Severe 44.8 0.453 52.6 1.039 59.1 1.088 36.4 0.647 43.5 0.568
New cases by year
2004 37.2 0.816 28.1 0.765 34.9 0.697 28.9 0.907 27.2 0.899 0.002
2005 39.2 0.687 34.0 0.947 29.7 0.828 25.7 0.745 23.9 0.729
2006 35.6 0.925 35.5 0.883 28.1 0.732 28.7 0.618 24.8 0.839
2007 30.7 0.911 33.0 0.734 27.6 0.944 22.1 0.635 24.5 0.921
2008 33.0 0.729 26.3 0.774 22.8 0.725 24.4 0.720 24.4 0.708
Hepatitis B
No 36.1 0.851 30.9 0.826 28.8 0.820 27.9 0.729 26.9 0.885 0.426
Yes 32.7 0.686 32.1 0.810 27.4 0.700 22.8 0.702 21.4 0.672
Hepatitis C
No 35.4 0.818 31.0 0.916 28.4 0.813 27.0 0.729 25.7 0.837 0.355
Yes 32.4 0.658 32.8 0.553 27.9 0.639 21.7 0.680 21.6 0.686
Alcoholic liver cirrhosis
No 32.3 0.854 28.3 0.860 25.6 0.782 24.0 0.737 24.2 0.834 <.001
Yes 62.1 0.560 63.7 0.671 56.6 0.740 51.6 0.638 44.0 0.579
Other (non-viral, non-alcoholic) liver cirrhosis
No 33.6 0.809 30.6 0.831 27.7 0.803 25.6 0.751 24.5 0.818 0.420
Yes 53.6 0.643 42.9 0.715 37.5 0.551 32.1 0.491 33.9 0.715
*Chisq-test, † Incidence per person-years
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provided a social safety net for middle-aged individuals,
who generally make larger economic contributions but
receive fewer welfare benefits compared to older individ-
uals [28]. The effects of low income on HCC mortality
often decrease in later life because of the increased avail-
ability of social welfare programs and access to health
care with lower amounts of out-of-pocket expenses ob-
served in older individuals [1, 3, 29]. Health behaviors
are plausible mediators of health disparities because of
social patterning and these influences on health out-
comes [30]. Among socially disadvantaged individuals,
for example, low-income individuals are prone to be
more influenced by sudden loss of wealth or a home,
perception of fewer benefits of health behaviors, and
pessimistic attitudes of later life [30].
This study had several limitations, and caution is re-
quired when interpreting the results and attempting to
generalize its findings. Although we analyzed all nation-
wide inpatient claims for HCC during a defined period,
Korea’s unique healthcare delivery and insurance system
might significantly limit generalizability of the results to
other nations. In addition, given the nature of the health
insurance claims dataset, this study retrospectively calcu-
lated the time of diagnosis of HCC patients. Although
we used the diagnostic information in the claims data,
we are confident that the time of diagnosis used in this
study reflects the time of actual diagnosis of HCC pa-
tients because we reviewed the claims in all available
years and excluded the first 2 years of data. However,
some degree of measurement error due to unavailability
of data on the actual time of diagnosis was unavoidable.
Therefore, additional research using cohort data should
be performed to verify the associations examined in this
study. In addition, potentially important clinical infor-
mation was not available. For example, we were not able
to access the detailed clinical information on HCC pa-
tients contained in the health insurance claims data col-
lected by the National Cancer Center. Although we
included duration from diagnosis to death or end of fol-
low up in the analytic models, additional clinical infor-
mation would have improved the validity of our
findings. Additional information, such as cancer stage,
site of cancer, and type of cancer, should be considered
in future studies to build on our findings and calibrate
estimates of the survival probability of HCC patients. In
addition, detailed individual- and community-level infor-
mation on SES was not available for our analyses. For
example, it might have been helpful to include educa-
tional attainment and income inequality indicators by
geographic unit because these can affect the health of
both poor and wealthy individuals due to spillover ef-
fects (e.g., psychological stress) of income inequality,
which can result in erosion of social cohesion [31, 32].
Additional studies should be conducted using a dataset
Table 3 Adjusted hazard ratios of hepatocellular carcinoma
mortality by multi-level





49 or younger Reference
50–59 1.691 <.001
60–69 3.338 <.001
70 or older 8.267 <.001
Income (quintiles)
The 5th (highest) Reference
The 4th 1.096 0.161
The 3rd 1.323 <.001
The 2nd 1.414 <.001
























Current smoking rate* 1.019 0.038
High-risk drinking rate* 0.994 0.331
Walking exercise practice rate * 0.996 0.037
Obesity rate * 1.003 0.634
Percentage of college graduates * 1.005 0.023
Income† 1.106 <.001
*Continuous variable at regional level † Trend test according to decrease
in income level
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Table 4 Adjusted hazard ratios of hepatocellular carcinoma mortality by sex and age groups
Variables Hazard ratio 95% Hazzard ratio confidence limits p-value
Male Income (quintiles)
The 5th (highest) Reference
The 4th 1.140 0.979 1.328 0.092
The 3rd 1.422 1.212 1.669 <.001
The 2nd 1.560 1.325 1.838 <.001
The 1st (lowest) 1.541 1.309 1.815 <.001
Trend test† 1.127 1.087 1.169 <.001
Female Income (quintiles)
The 5th (highest) Reference
The 4th 1.033 0.810 1.318 0.794
The 3rd 1.107 0.857 1.429 0.436
The 2nd 1.129 0.862 1.477 0.379
The 1st (lowest) 1.265 0.995 1.607 0.055
Trend test† 1.057 1.000 1.118 0.049
Age 49 or younger Income (quintiles)
The 5th (highest) Reference
The 4th 1.270 0.929 1.735 0.135
The 3rd 1.595 1.166 2.181 0.004
The 2nd 1.714 1.239 2.371 0.001
The 1st (lowest) 1.568 1.121 2.193 0.009
Trend test† 1.131 1.052 1.215 0.001
Age 50–59 Income (quintiles)
The 5th (highest) Reference
The 4th 1.509 1.105 2.059 0.010
The 3rd 1.593 1.151 2.204 0.005
The 2nd 2.089 1.512 2.887 <.001
The 1st (lowest) 2.197 1.586 3.043 <.001
Trend test† 1.209 1.126 1.298 <.001
Age 60–69 Income (quintiles)
The 5th (highest) Reference
The 4th 1.116 0.875 1.423 0.377
The 3rd 1.474 1.147 1.895 0.003
The 2nd 1.355 1.036 1.772 0.026
The 1st (lowest) 1.354 1.044 1.757 0.022
Trend test† 1.087 1.026 1.150 0.004
Age 70 or older Income (quintiles)
The 5th (highest) Reference
The 4th 0.967 0.777 1.202 0.759
The 3rd 1.140 0.894 1.454 0.292
The 2nd 1.074 0.841 1.372 0.569
The 1st (lowest) 1.177 0.945 1.466 0.146
Trend test† 1.042 0.991 1.096 0.111
*All adjusted by sex, age group, disability, new cases by year, hepatitis B, hepatitis C, alcoholic liver cirrhosis, other (non-viral, non-alcoholic) liver cirrhosis and
regional level(current smoking rate, high-risk drinking rate, walking exercise practice rate, obesity rate, percentage of college graduates). †Trend test according to
decrease in income level
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with more detailed matching of NHI claims data as well
as more information on SES.
Despite these limitations, to the best of our knowledge,
this is the one of only a few studies to analyze the Ko-
rean national claims dataset of HCC patients and to ex-
plore individual- and community-level factors associated
with the survival probability of these individuals.
Conclusions
Having a low income significantly affected the overall 5-
year mortality of Korean adults who were newly diag-
nosed with HCC from 2004 to 2008. Middle-aged men
were the most vulnerable. We believe our findings will
be useful to healthcare policymakers in Korea as well as
to healthcare leaders in countries with NHI programs
who need to make important decisions about allocation
of limited healthcare resources according to a consensu-
ally accepted and rational framework. Our findings also
add to the mounting empirical support for development
of a national cancer management strategy to narrow the
gaps in, for example, survival time and access to health-
care according to demographic characteristics, including
SES.
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